Tetherex Pharmaceuticals

Tetherex Pharmaceuticals is a privately held clinical-stage biopharmaceutical company founded in 2014 and headquartered in Oklahoma City, Oklahoma, focusing on biotechnology operations. The company develops inhibitor therapies for infectious diseases as well as single-cycle adenovirus vaccines for various infectious diseases and cancer indications.